• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿琥酯是否会延长重症疟疾患者的心电图QT间期?

Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?

作者信息

Maude Richard J, Plewes Katherine, Faiz M Abul, Hanson Josh, Charunwatthana Prakaykaew, Lee Sue J, Tärning Joel, Yunus Emran Bin, Hoque M Gofranul, Hasan Mahatab Uddin, Hossain Amir, Lindegardh Niklas, Day Nicholas P J, White Nicholas J, Dondorp Arjen M

机构信息

Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.

出版信息

Am J Trop Med Hyg. 2009 Jan;80(1):126-32. doi: 10.4269/ajtmh.2009.08-0326.

DOI:10.4269/ajtmh.2009.08-0326
PMID:19141850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2843440/
Abstract

Several antimalarials can cause significant prolongation of the electrocardiograph QT interval, which can be associated with an increased risk of potentially lethal ventricular arrhythmias. High doses of artemether and artemotil have been associated with QT prolongation in dogs, raising the possibility of a class effect with the artemisinin derivatives. Serial electrocardiograms were recorded, and QTc interval was calculated before and after administration of artesunate by intravenous injection in patients with severe falciparum malaria in Bangladesh. Of 21 adult patients with severe malaria enrolled, 8 (38%) died. The mean QTc interval was unaffected by bolus intravenous artesunate (2.4 mg/kg). In two patients, the QTc interval exceeded 0.5 seconds, but in both cases, an alternative explanation was plausible. No effect was observed on the JTc or PR interval, QRS width, blood pressure, or heart rate. Intravenous artesunate does not have significant cardiovascular effects in patients with severe falciparum malaria.

摘要

几种抗疟药可导致心电图QT间期显著延长,这可能与潜在致命性室性心律失常风险增加有关。高剂量的蒿甲醚和青蒿琥酯已被证明与犬的QT间期延长有关,这增加了青蒿素衍生物存在类效应的可能性。在孟加拉国,对患有严重恶性疟原虫疟疾的患者静脉注射青蒿琥酯前后记录了系列心电图,并计算了QTc间期。在纳入的21例严重疟疾成年患者中,8例(38%)死亡。静脉推注青蒿琥酯(2.4mg/kg)对平均QTc间期无影响。有2例患者的QTc间期超过0.5秒,但在这两种情况下,都有其他合理的解释。未观察到对JTc或PR间期、QRS波宽度、血压或心率有影响。静脉注射青蒿琥酯对患有严重恶性疟原虫疟疾的患者没有显著的心血管影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/2843440/e1a235ab4fb8/tropmed-80-126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/2843440/9e8ad15021e2/tropmed-80-126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/2843440/7041f69bc364/tropmed-80-126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/2843440/e1a235ab4fb8/tropmed-80-126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/2843440/9e8ad15021e2/tropmed-80-126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/2843440/7041f69bc364/tropmed-80-126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/2843440/e1a235ab4fb8/tropmed-80-126-g003.jpg

相似文献

1
Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?青蒿琥酯是否会延长重症疟疾患者的心电图QT间期?
Am J Trop Med Hyg. 2009 Jan;80(1):126-32. doi: 10.4269/ajtmh.2009.08-0326.
2
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.用无校正和无心率校正方法评价 4 种青蒿素类复方抗疟药对 QT 间期的影响。
Sci Rep. 2019 Jan 29;9(1):883. doi: 10.1038/s41598-018-37113-5.
3
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.吡喹酮-青蒿琥酯或双氢青蒿素-哌喹与当前一线疗法用于复发性无并发症疟疾的多次治疗:一项随机、多中心、开放标签、纵向、对照、3b/4 期试验。
Lancet. 2018 Apr 7;391(10128):1378-1390. doi: 10.1016/S0140-6736(18)30291-5. Epub 2018 Mar 29.
4
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.马来西亚沙巴州一家三级护理医院的严重 knowlesi 疟疾病例。
Emerg Infect Dis. 2011 Jul;17(7):1248-55. doi: 10.3201/eid1707.101017.
5
Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.青蒿琥酯-阿莫地喹对埃博拉病毒病相关死亡率的影响。
N Engl J Med. 2016 Jan 7;374(1):23-32. doi: 10.1056/NEJMoa1504605.
6
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.柬埔寨恶性疟原虫中Pfmdr1基因拷贝数与青蒿素衍生物联合疗法失败情况
Malar J. 2009 Jan 12;8:11. doi: 10.1186/1475-2875-8-11.
7
Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants.抗疟药复方蒿甲醚和卤泛群对健康受试者心脏影响的比较。
Am J Trop Med Hyg. 2002 Mar;66(3):293-8. doi: 10.4269/ajtmh.2002.66.293.
8
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.蒿甲醚-本芴醇用于治疗多重耐药恶性疟。
Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):545-8. doi: 10.1016/s0035-9203(00)90082-8.
9
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.青蒿琥酯-阿莫地喹与蒿甲醚-本芴醇治疗妊娠期急性非复杂性疟疾的随机试验。
Int J Gynaecol Obstet. 2015 Oct;131(1):41-4. doi: 10.1016/j.ijgo.2015.05.009. Epub 2015 Jul 3.
10
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.蒿甲醚+阿莫地喹、蒿甲醚+氯胍-氨苯砜及青蒿琥酯-卢美芬净治疗非重症疟疾的开放标签随机试验
PLoS One. 2008 Jun 25;3(6):e2530. doi: 10.1371/journal.pone.0002530.

引用本文的文献

1
Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive proarrhythmia assay (CiPA).使用综合心律失常检测法(CiPA)评估用于治疗COVID-19的重新利用的抗疟药的促心律失常作用。
Front Pharmacol. 2023 Aug 15;14:1220796. doi: 10.3389/fphar.2023.1220796. eCollection 2023.
2
Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies.心血管浓度-效应关系的阿莫地喹及其代谢产物去乙基阿莫地喹:临床和临床前研究。
Br J Clin Pharmacol. 2023 Mar;89(3):1176-1186. doi: 10.1111/bcp.15569. Epub 2022 Nov 8.
3

本文引用的文献

1
Cardiotoxicity of antimalarial drugs.抗疟药物的心脏毒性。
Lancet Infect Dis. 2007 Aug;7(8):549-58. doi: 10.1016/S1473-3099(07)70187-1.
2
Antimicrobial-associated QT interval prolongation: pointes of interest.抗菌药物相关的QT间期延长:关注点
Clin Infect Dis. 2006 Dec 15;43(12):1603-11. doi: 10.1086/508873. Epub 2006 Nov 8.
3
Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data.
Usher syndrome IIIA: a review of the disorder and preclinical research advances in therapeutic approaches.
III型Usher综合征A:疾病综述及治疗方法的临床前研究进展
Hum Genet. 2022 Apr;141(3-4):759-783. doi: 10.1007/s00439-022-02446-9. Epub 2022 Mar 23.
4
CMCH and MORU: a Highly Successful Collaboration.CMCH与MORU:一次非常成功的合作。
J Chittagong Med Coll Teach Assoc. 2010 May;20(1):2-5. doi: 10.3329/jcmcta.v20i1.4926.
5
The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis.抗疟药阿莫地喹及其结构类似物的心血管效应:一项个体患者数据分析荟萃分析。
PLoS Med. 2021 Sep 7;18(9):e1003766. doi: 10.1371/journal.pmed.1003766. eCollection 2021 Sep.
6
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries.在六个欧洲国家开展的基于阿莫地喹-哌喹治疗疟疾患者安全性注册登记的纵向研究。
Malar J. 2021 May 8;20(1):214. doi: 10.1186/s12936-021-03750-x.
7
Development and Validation of an Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients.开发并验证一个决策工具,以指导优化重症恶性疟患者的静脉注射青蒿琥酯给药方案。
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02346-20.
8
Cardiac Arrhythmia in a Patient with Sickle Cell Anemia and Falciparum Malaria Treated with Intravenous Artesunate.静脉注射青蒿琥酯治疗镰状细胞贫血和恶性疟患者时出现的心律失常
Case Rep Infect Dis. 2019 Nov 13;2019:1913685. doi: 10.1155/2019/1913685. eCollection 2019.
9
Unconventional secretory pathway activation restores hair cell mechanotransduction in an USH3A model.非传统分泌途径激活可恢复 USH3A 模型中的毛细胞机械转导。
Proc Natl Acad Sci U S A. 2019 May 28;116(22):11000-11009. doi: 10.1073/pnas.1817500116. Epub 2019 May 16.
10
Hematological and biochemical effects of sub-chronic artesunate exposure in rats.大鼠亚慢性青蒿琥酯暴露的血液学和生化效应
Toxicol Rep. 2015 Jan 25;2:280-288. doi: 10.1016/j.toxrep.2015.01.007. eCollection 2015.
蒿甲醚-本芴醇六剂疗法治疗儿童单纯性恶性疟的疗效与安全性:个体患者数据的汇总分析
Am J Trop Med Hyg. 2006 Jun;74(6):991-8.
4
Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.非抗心律失常药物QT/QTc间期延长及促心律失常风险的临床评估:人用药品注册技术要求国际协调会E14指南
J Clin Pharmacol. 2006 May;46(5):498-507. doi: 10.1177/0091270006286436.
5
Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.药物、QTc间期延长与ICH E14最终指南:一个具有里程碑意义但前路仍有挑战的事件
Drug Saf. 2005;28(11):1009-28. doi: 10.2165/00002018-200528110-00003.
6
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.青蒿琥酯与奎宁治疗重症恶性疟的随机对照试验
Lancet. 2005;366(9487):717-25. doi: 10.1016/S0140-6736(05)67176-0.
7
Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria.双氢青蒿素哌喹片(科泰复)用于柬埔寨疟疾儿童及成人的安全性评估
Br J Clin Pharmacol. 2004 Jan;57(1):93-9. doi: 10.1046/j.1365-2125.2003.01962.x.
8
Risk stratification in the long-QT syndrome.长QT综合征的风险分层
N Engl J Med. 2003 May 8;348(19):1866-74. doi: 10.1056/NEJMoa022147.
9
Studies of the neurotoxicity of oral artemisinin derivatives in mice.口服青蒿素衍生物对小鼠神经毒性的研究。
Am J Trop Med Hyg. 2000 Mar;62(3):409-12. doi: 10.4269/ajtmh.2000.62.409.
10
A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.印度一项关于口服蒿甲醚与口服氯喹治疗成人急性非复杂性恶性疟原虫疟疾的随机、双盲、平行组、比较安全性和疗效试验。
Am J Trop Med Hyg. 2000 Mar;62(3):402-8. doi: 10.4269/ajtmh.2000.62.402.